Affluent Medical | Finanzwire

Basculer en Français

10827	Companies
234890	Keywords
163749	Articles
125724	Press releases

Home
Companies
Affluent Medical

PRESS RELEASE

published on 06/18/2024 at 17:45, 2 years 1 month ago

Affluent Medical achieves the clinical objective of the Dry pilot study in the first two patients with the Artus artificial urinary sphincter
Affluent Medical achieves clinical objective of Dry pilot study in first two patients with Artus artificial urinary sphincter, marking successful activation and ease of implantation. Company progresses towards goal of study

Medical Device Affluent Medical Urinary Incontinence Dry Pilot Study Artus Artificial Urinary Sphincter
PRESS RELEASE

published on 06/18/2024 at 17:45, 2 years 1 month ago

Affluent Medical achieves the clinical objective of the Dry pilot study in the first two patients with the Artus artificial urinary sphincter.
Affluent Medical successfully activates Artus artificial urinary sphincter in first two patients, addressing global incontinence need. Read more about the innovative medical device here

Medical Device Affluent Medical Clinical Study Urinary Incontinence Artus
BRIEF

published on 06/14/2024 at 17:50, 2 years 1 month ago

Affluent Medical: Number of shares making up the share capital and total number of voting rights as of 05/30/24

Voting Rights Euronext Actions AMF Affluent Medical
BRIEF

published on 06/03/2024 at 11:33, 2 years 2 months ago

Affluent Medical: Ordinary Annual and Extraordinary General Meeting of June 24, 2024

Shareholders Affluent Medical General Assembly Preparatory Documents Aix En Provence
BRIEF

published on 05/31/2024 at 17:45, 2 years 2 months ago

Affluent Medical: Number of shares and voting rights as of February 29, 2024

Euronext Paris Voting Rights Actions Regulation Affluent Medical
BRIEF

published on 05/31/2024 at 17:45, 2 years 2 months ago

Affluent Medical: Number of shares and voting rights as of March 31, 2024

Share Capital Voting Rights Actions Regulation Affluent Medical
BRIEF

published on 05/31/2024 at 17:45, 2 years 2 months ago

Affluent Medical: Number of shares and voting rights as of April 30, 2024

Share Capital Voting Rights Actions Affluent Medical Regulatory Information
BRIEF

published on 04/30/2024 at 19:29, 2 years 3 months ago

Affluent Medical announces the publication of its 2023 Universal Registration Document

Annual Financial Report Affluent Medical MedTech Universal Registration Document DEU 2023
BRIEF

published on 04/25/2024 at 17:50, 2 years 3 months ago

Affluent Medical announces its 2023 results and the progression of its clinical activities

Medical Devices American Market 2023 Financial Results Clinical Studies MedTech Innovations
PRESS RELEASE

published on 04/25/2024 at 17:45, 2 years 3 months ago

Affluent Medical : 2023 financial results and update on clinical activities under development.
Affluent Medical releases 2023 financial results and updates on clinical activities, including positive outcomes for Kalios mitral ring and Epygon valve. Strategic shift towards US market

Financial Results Affluent Medical Epygon Valve Clinical Activities Kalios Mitral Ring

Accesswire

Published on 08/12/2026 at 15:42, 5 hours 43 minutes ago

Critical Elements 10,000-Meter Summer Drill Program at Rose West Resumes with Positive Results
Published on 08/12/2026 at 15:00, 6 hours 25 minutes ago

Karbon-X and Core Energy Sign Letter of Intent to Explore Commercial EV Charging Infrastructure in South America
Published on 08/12/2026 at 14:45, 6 hours 40 minutes ago

Lobe Sciences Ltd. Announces Non-Brokered Private Placement
Published on 08/12/2026 at 14:30, 6 hours 55 minutes ago

Recent Corporate Events Recap
Published on 08/12/2026 at 14:00, 7 hours 25 minutes ago

International Battery Metals Appoints Scott Colangelo to Board of Directors

View all ACCESSWIRE

EQS Group

Published on 08/12/2026 at 21:05, 20 minutes ago

Aurisco Pharmaceutical is the First Generic Oligonucleotide Manufacturer in the World successfully inspected by USFDA
Published on 08/12/2026 at 19:57, 1 hour 27 minutes ago

EQS-Adhoc: Hypoport SE: Hypoport SE resolves share buyback programme with a volume of up to EUR 10 million
Published on 08/12/2026 at 19:37, 1 hour 47 minutes ago

EQS-Adhoc: Brockhaus Technologies AG: Preliminary revenue for H1 2026 at €13.4 million and adjusted EBITDA at €-0.5 million; forecast for the continuing operations unchanged
Published on 08/12/2026 at 18:50, 2 hours 35 minutes ago

Holding(s) in Company
Published on 08/12/2026 at 18:29, 2 hours 56 minutes ago

Designated Persons Notifications

Les Echos

Published on 08/10/2026 at 18:00, 2 days 3 hours ago

AXA: Information relating to the number of voting rights and shares making up the share capital on 31/07/2026
Published on 08/10/2026 at 17:45, 2 days 3 hours ago

Weekly share buyback
Published on 08/10/2026 at 11:53, 2 days 9 hours ago

GUILLEMOT CORPORATION | Information regarding the total number of voting rights and shares 31/07/2026
Published on 08/10/2026 at 11:36, 2 days 9 hours ago

GUILLEMOT CORPORATION| Weekly report share buyback from August 3 to August 7 2026
Published on 08/10/2026 at 09:22, 2 days 12 hours ago

Number of shares and voting rights - July 2026 (In French only)

View all LES ECHOS COMFI WIRE